OTC Markets EXMKT - Delayed Quote USD
Antibe Therapeutics Inc. (ATBPF)
0.2160
0.0000
(0.00%)
At close: April 16 at 4:00:00 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 4.18M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| Curtis (Scott Wilson) Senior Officer of Issuer | Acquisition or disposition in the public market at price 0.39 per share. | Direct | 5,790 | Mar 7, 2024 |
| Legault (Daniel Marcel) Director of Issuer | Acquisition or disposition in the public market at price 0.37 per share. | Direct | 7,440 | Mar 7, 2024 |
Related Tickers
BIOAF Bioasis Technologies Inc.
0.0004
0.00%
MMIRF MedMira Inc.
0.0207
0.00%
MSCL.TO Satellos Bioscience Inc.
0.6200
0.00%
MIR.V MedMira Inc.
0.0900
-5.26%
MDNAF Medicenna Therapeutics Corp.
0.7940
+3.79%
ONC.TO Oncolytics Biotech Inc.
0.8400
+6.33%
TVGN Tevogen Bio Holdings Inc.
0.9691
+3.95%
CNTB Connect Biopharma Holdings Limited
0.6998
-6.31%